FFCP PHASE1:Mm9::chr5:122970815..122970819,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=10|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr5:122970815..122970819,-|id=chr5:122970815..122970819,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0007100!1.13e-38!18;UBERON:0000948!1.13e-38!18;UBERON:0005498!1.13e-38!18;UBERON:0004140!1.13e-38!18;UBERON:0009881!1.13e-38!18;UBERON:0004141!1.13e-38!18;UBERON:0003084!1.13e-38!18;UBERON:0007005!1.13e-38!18;UBERON:0004139!1.13e-38!18;UBERON:0004291!1.13e-38!18;UBERON:0004535!2.59e-30!23;UBERON:0001009!2.59e-30!23;UBERON:0004872!3.59e-21!33;UBERON:0003103!2.91e-16!43;UBERON:0003914!7.01e-15!47;UBERON:0003081!6.59e-08!88|ontology_enrichment_uberon_v019_2=UBERON:0007100,1.68e-15,18;UBERON:0000948,1.68e-15,18;UBERON:0005498,1.68e-15,18;UBERON:0004140,1.68e-15,18;UBERON:0009881,1.68e-15,18;UBERON:0004141,1.68e-15,18;UBERON:0003084,1.68e-15,18;UBERON:0007005,1.68e-15,18;UBERON:0004139,1.68e-15,18;UBERON:0004291,1.68e-15,18;UBERON:0004535,2.24e-12,23;UBERON:0001009,2.24e-12,23;UBERON:0004872,6.05e-09,33;UBERON:0003103,4.30e-07,43|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232533944750408,0,0.233530684734339,0.16455984991348,0.492502392237286,1.21603214318784,3.07019973593198,1.09775057645525,0.939444931322602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr5:122970815..122970819,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=10 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr5:122970815..122970819,- | |||
|description=CAGE_peak_at_chr5:122970815..122970819,- | |||
|id=chr5:122970815..122970819,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0007100!1.13e-38!18;UBERON:0000948!1.13e-38!18;UBERON:0005498!1.13e-38!18;UBERON:0004140!1.13e-38!18;UBERON:0009881!1.13e-38!18;UBERON:0004141!1.13e-38!18;UBERON:0003084!1.13e-38!18;UBERON:0007005!1.13e-38!18;UBERON:0004139!1.13e-38!18;UBERON:0004291!1.13e-38!18;UBERON:0004535!2.59e-30!23;UBERON:0001009!2.59e-30!23;UBERON:0004872!3.59e-21!33;UBERON:0003103!2.91e-16!43;UBERON:0003914!7.01e-15!47;UBERON:0003081!6.59e-08!88 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0007100,1.68e-15,18;UBERON:0000948,1.68e-15,18;UBERON:0005498,1.68e-15,18;UBERON:0004140,1.68e-15,18;UBERON:0009881,1.68e-15,18;UBERON:0004141,1.68e-15,18;UBERON:0003084,1.68e-15,18;UBERON:0007005,1.68e-15,18;UBERON:0004139,1.68e-15,18;UBERON:0004291,1.68e-15,18;UBERON:0004535,2.24e-12,23;UBERON:0001009,2.24e-12,23;UBERON:0004872,6.05e-09,33;UBERON:0003103,4.30e-07,43 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232533944750408,0,0.233530684734339,0.16455984991348,0.492502392237286,1.21603214318784,3.07019973593198,1.09775057645525,0.939444931322602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr5:122970815..122970819,- | |||
}} |
Latest revision as of 05:59, 6 August 2015
Short description: | p@chr5:122970815..122970819, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr5:122970815..122970819, - |
Coexpression cluster: | MCL_coexpression_mm9:10 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
primary circulatory organ | 1.68e-15 | 18 |
heart | 1.68e-15 | 18 |
primitive heart tube | 1.68e-15 | 18 |
primary heart field | 1.68e-15 | 18 |
anterior lateral plate mesoderm | 1.68e-15 | 18 |
heart tube | 1.68e-15 | 18 |
heart primordium | 1.68e-15 | 18 |
cardiac mesoderm | 1.68e-15 | 18 |
cardiogenic plate | 1.68e-15 | 18 |
heart rudiment | 1.68e-15 | 18 |
cardiovascular system | 2.24e-12 | 23 |
circulatory system | 2.24e-12 | 23 |
splanchnic layer of lateral plate mesoderm | 6.05e-09 | 33 |
compound organ | 4.30e-07 | 43 |